对于AML的HCT后维持疗法:谁,什么时候,为什么,多久?
1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
在急性髓性白血病 (AML) 患者中,全基性造血细胞移植 (HCT) 非常重要. 然而,尽管使用后的HCT维持疗法缺乏强有力的证据,这凸显了进一步研究的需要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 全基性造血细胞移植 (HCT) 是急性髓性白血病 (AML) 的关键治愈疗法,以预防疾病复发.
- 尽管HCT的有效性,复发仍然是一个问题,导致使用后HCT维持治疗.
- 支持大多数HCT后AML维持疗法的疗效的证据有限或不存在.
研究的目的:
- 审查现有数据,或缺乏数据,支持在AML中使用后HCT维持疗法.
- 讨论在AML患者中使用分子向药物进行HCT后的维持治疗的潜在好处和陷.
- 提供对AML后HCT维护当前实践的批判性评估.
主要方法:
- 随机对照试验和临床研究的文献综述.
- 对包括FLT3抑制剂在内的分子向药物数据的分析.
- 评估证据支持使用维护疗法在AML的HCT的背景下.
主要成果:
- 随机数据支持FLT3抑制剂作为维持疗法在HCT后选择的AML患者的使用.
- 目前,用于HCT后AML维护的其他药物类别的证据不足.
- 提供维持治疗的做法是常见的,但往往不是基于强大的临床试验数据.
结论:
- 虽然FLT3抑制剂显示出有前途,但对于AML中HCT后的其他维持疗法的强有力的证据仍然需要.
- 临床医生继续使用维持疗法,希望改善结果,需要仔细考虑现有数据.
- 需要进一步的研究,以确定在接受HCT的AML患者中各种维护策略的有效性和安全性.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.9K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
604
相关概念视频
01:30Continuous Renal Replacement Therapy
752
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
752
01:22Myocarditis IV: Nursing Management
196
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
196
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.2K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.2K
01:16Kidney Transplant III: Nursing Management
294
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
294
01:19Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
01:22Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235